ID

40117

Description

Effects of Cocoa on Ambulatory Blood Pressure and Vascular Function in Patients With Stage I Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01672840

Link

https://clinicaltrials.gov/show/NCT01672840

Keywords

  1. 3/12/20 3/12/20 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 12, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT01672840

Eligibility Hypertension NCT01672840

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women age 18-75 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
stage 1 hypertension (i.e. 140-159/90-99 mmhg) without anti-hypertensive medication or with only one anti-hypertensive medicaion
Description

Hypertensive disease Stage | Blood pressure determination | Antihypertensive Agents Absent | Antihypertensive Agents Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0699749
UMLS CUI [2]
C0005824
UMLS CUI [3,1]
C0003364
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0003364
UMLS CUI [4,2]
C1265611
body mass index < 35 kg/m²
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
willing to discontinue the use of chocolate/cocoa products at least 4 weeks prior to intervention.
Description

Intake Chocolate Discontinue | Intake Cocoa Discontinue

Data type

boolean

Alias
UMLS CUI [1,1]
C1512806
UMLS CUI [1,2]
C0008299
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C1512806
UMLS CUI [2,2]
C4521844
UMLS CUI [2,3]
C1444662
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
anticipated inability to complete or comply with study protocol
Description

Completion of clinical trial Unable | Protocol Compliance Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C2732579
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C1299582
use of lipid-lowering or aspirin unless stable on medication for at least 1 month and willing to refrain from taking medication for 12 hours prior to endothelial function scanning
Description

Hypolipidemic Agents | Aspirin | Exception Medication Stable | Exception Medication Discontinuation

Data type

boolean

Alias
UMLS CUI [1]
C0086440
UMLS CUI [2]
C0004057
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0013227
UMLS CUI [4,3]
C1444662
severe hypertension (systolic blood pressure >160mmhg or diastolic blood pressure >100 mmhg), or use more than one anti-hypertensive medications
Description

Hypertension, severe | Systolic Pressure | Diastolic blood pressure | Antihypertensive Agents Quantity

Data type

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
UMLS CUI [4,1]
C0003364
UMLS CUI [4,2]
C1265611
allergic to cocoa products (chocolate or cocoa powder)
Description

Hypersensitivity Cocoa | Hypersensitivity Chocolate | Hypersensitivity Cocoa Powder

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C4521844
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0008299
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0009209
regular use of vitamin c, vitamin e, fish oil, flax seed oil, omega-3 fatty acids, coenzyme q10, fiber supplements, garlic pills, arginine, red yeast rice, and/or any kind of antioxidant and unwilling to discontinue supplementation for at least 4 weeks prior to study initiation and for the study duration. use of a multi-vitamin containing no more than two times the recommended daily allowance for vitamins c and e is permissible
Description

Ascorbic Acid Regular | Vitamin E Regular | Fish Oil Regular | Flax Seed Oil Regular | Omega-3 Fatty Acids Regular | Coenzyme Q10 Regular | Fiber Supplements Regular | Garlic Pills Regular | Arginine Regular | Red yeast rice Regular | Antioxidants Regular | Supplementation Discontinue Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C0003968
UMLS CUI [1,2]
C0205272
UMLS CUI [2,1]
C0042874
UMLS CUI [2,2]
C0205272
UMLS CUI [3,1]
C0016157
UMLS CUI [3,2]
C0205272
UMLS CUI [4,1]
C1170277
UMLS CUI [4,2]
C0205272
UMLS CUI [5,1]
C0015689
UMLS CUI [5,2]
C0205272
UMLS CUI [6,1]
C0056077
UMLS CUI [6,2]
C0205272
UMLS CUI [7,1]
C0012173
UMLS CUI [7,2]
C0242295
UMLS CUI [7,3]
C0205272
UMLS CUI [8,1]
C0993630
UMLS CUI [8,2]
C0994475
UMLS CUI [8,3]
C0205272
UMLS CUI [9,1]
C0003765
UMLS CUI [9,2]
C0205272
UMLS CUI [10,1]
C0763533
UMLS CUI [10,2]
C0205272
UMLS CUI [11,1]
C0003402
UMLS CUI [11,2]
C0205272
UMLS CUI [12,1]
C0242297
UMLS CUI [12,2]
C1444662
UMLS CUI [12,3]
C0558080
diagnosed eating disorder
Description

Eating Disorder

Data type

boolean

Alias
UMLS CUI [1]
C0013473
on any specific diet, weight control diet, and/or vegan diet
Description

Diet Specific | Diet Weight Control | Vegan diet

Data type

boolean

Alias
UMLS CUI [1,1]
C0012155
UMLS CUI [1,2]
C0205369
UMLS CUI [2,1]
C0012155
UMLS CUI [2,2]
C0005910
UMLS CUI [2,3]
C2587213
UMLS CUI [3]
C0344353
substance abuse (chronic alcoholism and/or other chemical dependency)
Description

Substance Use Disorders | Alcoholic Intoxication, Chronic | Substance Dependence

Data type

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0001973
UMLS CUI [3]
C0038580
any unstable medical condition that would limit the ability of a subject to participate fully in the trial (e.g., cancer, aids, tuberculosis, psychotic disorder)
Description

Medical condition Unstable | Ability Limited Completion of clinical trial | Malignant Neoplasms | AIDS | Tuberculosis | Psychotic Disorder

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0443343
UMLS CUI [2,1]
C0085732
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C2732579
UMLS CUI [3]
C0006826
UMLS CUI [4]
C0001175
UMLS CUI [5]
C0041296
UMLS CUI [6]
C0033975
current or impending pregnancy. in premenopausal women, pregnancy will be excluded by pregnancy test at the time of each study visit.
Description

Pregnancy | Pregnancy Impending | Premenopausal state Pregnancy Test

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332190
UMLS CUI [3,1]
C0232969
UMLS CUI [3,2]
C0032976

Similar models

Eligibility Hypertension NCT01672840

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
men and women age 18-75 years
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease Stage | Blood pressure determination | Antihypertensive Agents Absent | Antihypertensive Agents Quantity
Item
stage 1 hypertension (i.e. 140-159/90-99 mmhg) without anti-hypertensive medication or with only one anti-hypertensive medicaion
boolean
C0020538 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
C0005824 (UMLS CUI [2])
C0003364 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0003364 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
Body mass index
Item
body mass index < 35 kg/m²
boolean
C1305855 (UMLS CUI [1])
Intake Chocolate Discontinue | Intake Cocoa Discontinue
Item
willing to discontinue the use of chocolate/cocoa products at least 4 weeks prior to intervention.
boolean
C1512806 (UMLS CUI [1,1])
C0008299 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C1512806 (UMLS CUI [2,1])
C4521844 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Completion of clinical trial Unable | Protocol Compliance Unable
Item
anticipated inability to complete or comply with study protocol
boolean
C2732579 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Hypolipidemic Agents | Aspirin | Exception Medication Stable | Exception Medication Discontinuation
Item
use of lipid-lowering or aspirin unless stable on medication for at least 1 month and willing to refrain from taking medication for 12 hours prior to endothelial function scanning
boolean
C0086440 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C1444662 (UMLS CUI [4,3])
Hypertension, severe | Systolic Pressure | Diastolic blood pressure | Antihypertensive Agents Quantity
Item
severe hypertension (systolic blood pressure >160mmhg or diastolic blood pressure >100 mmhg), or use more than one anti-hypertensive medications
boolean
C4013784 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C0003364 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
Hypersensitivity Cocoa | Hypersensitivity Chocolate | Hypersensitivity Cocoa Powder
Item
allergic to cocoa products (chocolate or cocoa powder)
boolean
C0020517 (UMLS CUI [1,1])
C4521844 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0008299 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0009209 (UMLS CUI [3,2])
Ascorbic Acid Regular | Vitamin E Regular | Fish Oil Regular | Flax Seed Oil Regular | Omega-3 Fatty Acids Regular | Coenzyme Q10 Regular | Fiber Supplements Regular | Garlic Pills Regular | Arginine Regular | Red yeast rice Regular | Antioxidants Regular | Supplementation Discontinue Unwilling
Item
regular use of vitamin c, vitamin e, fish oil, flax seed oil, omega-3 fatty acids, coenzyme q10, fiber supplements, garlic pills, arginine, red yeast rice, and/or any kind of antioxidant and unwilling to discontinue supplementation for at least 4 weeks prior to study initiation and for the study duration. use of a multi-vitamin containing no more than two times the recommended daily allowance for vitamins c and e is permissible
boolean
C0003968 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0042874 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C0016157 (UMLS CUI [3,1])
C0205272 (UMLS CUI [3,2])
C1170277 (UMLS CUI [4,1])
C0205272 (UMLS CUI [4,2])
C0015689 (UMLS CUI [5,1])
C0205272 (UMLS CUI [5,2])
C0056077 (UMLS CUI [6,1])
C0205272 (UMLS CUI [6,2])
C0012173 (UMLS CUI [7,1])
C0242295 (UMLS CUI [7,2])
C0205272 (UMLS CUI [7,3])
C0993630 (UMLS CUI [8,1])
C0994475 (UMLS CUI [8,2])
C0205272 (UMLS CUI [8,3])
C0003765 (UMLS CUI [9,1])
C0205272 (UMLS CUI [9,2])
C0763533 (UMLS CUI [10,1])
C0205272 (UMLS CUI [10,2])
C0003402 (UMLS CUI [11,1])
C0205272 (UMLS CUI [11,2])
C0242297 (UMLS CUI [12,1])
C1444662 (UMLS CUI [12,2])
C0558080 (UMLS CUI [12,3])
Eating Disorder
Item
diagnosed eating disorder
boolean
C0013473 (UMLS CUI [1])
Diet Specific | Diet Weight Control | Vegan diet
Item
on any specific diet, weight control diet, and/or vegan diet
boolean
C0012155 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0012155 (UMLS CUI [2,1])
C0005910 (UMLS CUI [2,2])
C2587213 (UMLS CUI [2,3])
C0344353 (UMLS CUI [3])
Substance Use Disorders | Alcoholic Intoxication, Chronic | Substance Dependence
Item
substance abuse (chronic alcoholism and/or other chemical dependency)
boolean
C0038586 (UMLS CUI [1])
C0001973 (UMLS CUI [2])
C0038580 (UMLS CUI [3])
Medical condition Unstable | Ability Limited Completion of clinical trial | Malignant Neoplasms | AIDS | Tuberculosis | Psychotic Disorder
Item
any unstable medical condition that would limit the ability of a subject to participate fully in the trial (e.g., cancer, aids, tuberculosis, psychotic disorder)
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0085732 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C2732579 (UMLS CUI [2,3])
C0006826 (UMLS CUI [3])
C0001175 (UMLS CUI [4])
C0041296 (UMLS CUI [5])
C0033975 (UMLS CUI [6])
Pregnancy | Pregnancy Impending | Premenopausal state Pregnancy Test
Item
current or impending pregnancy. in premenopausal women, pregnancy will be excluded by pregnancy test at the time of each study visit.
boolean
C0032961 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332190 (UMLS CUI [2,2])
C0232969 (UMLS CUI [3,1])
C0032976 (UMLS CUI [3,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial